Literature DB >> 16901030

The early history of giant cell arteritis and polymyalgia rheumatica: first descriptions to 1970.

Gene G Hunder1.   

Abstract

Giant cell arteritis and polymyalgia rheumatica were described separately more than 100 years ago. However, the original reports of both conditions were neglected for many years. After the article by Horton et al on giant cell arteritis in the 1930s and studies published by others in the 1940s, giant cell arteritis began to be recognized as a specific disease. In the 1950s and 1960s, many of the numerous presentations and complications of giant cell arteritis were recorded. In a somewhat similar fashion, physicians became cognizant of polymyalgia rheumatica only after several independent descriptions in the 1940s and 1950s. The rapid response of both syndromes to glucocorticoid therapy was discovered shortly after cortisone's effect on rheumatoid arthritis was described. The origin of the proximal aching and stiffness in polymyalgia rheumatica was more difficult to understand. The relatively minor findings in the joints on physical examination seemed insufficient to account for the severe discomfort. As the link between polymyalgia rheumatica and giant cell arteritis became apparent, some thought the aching in polymyalgia rheumatica was related to vasculitis. The debate about whether proximal synovitis or vasculitis was the cause of the symptoms continued after 1970. Although the reason these 2 conditions were associated was not considered by 1970, the establishment of the syndromes as clinically linked entities provided the groundwork for further progress in the next decades.

Entities:  

Mesh:

Year:  2006        PMID: 16901030     DOI: 10.4065/81.8.1071

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

1.  Gastric bleeding in giant cell arteritis.

Authors:  Austin Childress; Thomas J Kwarcinski; Joseph Scott H Bittle; Clayton Trimmer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-15

2.  Vasculitides throughout history and their clinical treatment today.

Authors:  Antonio Iglesias-Gamarra; Edgar Penaranda; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

3.  Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis.

Authors:  Hisham M Habib; Ashraf A Essa; Ayman A Hassan
Journal:  Clin Rheumatol       Date:  2011-07-09       Impact factor: 2.980

Review 4.  Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein.

Authors:  A Laria; A Zoli; M Bocci; F Castri; F Federico; G F Ferraccioli
Journal:  Clin Rheumatol       Date:  2012-07-22       Impact factor: 2.980

Review 5.  Clinical features of polymyalgia rheumatica and giant cell arteritis.

Authors:  Carlo Salvarani; Nicolò Pipitone; Annibale Versari; Gene G Hunder
Journal:  Nat Rev Rheumatol       Date:  2012-07-24       Impact factor: 20.543

6.  Scalp necrosis as a late sign of giant-cell arteritis.

Authors:  Mohammad Alimohammadi; Ann Knight
Journal:  Case Reports Immunol       Date:  2013-01-09

7.  Color duplex ultrasonography findings of temporal arteries in a case of giant cell arteritis: role in diagnosis and follow-up.

Authors:  Antonella Laria; Alfredo Lurati; Magda Scarpellini
Journal:  Open Access Rheumatol       Date:  2017-03-15

8.  Messages from the history of polymyalgia rheumatica.

Authors:  Ciro Manzo
Journal:  Reumatologia       Date:  2021-12-30

9.  Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Yannick van Sleen; Jacoba C Graver; Wayel H Abdulahad; Kornelis S M van der Geest; Annemieke M H Boots; Maria Sandovici; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

Review 10.  Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.

Authors:  Andriko Palmowski; Frank Buttgereit
Journal:  Curr Rheumatol Rep       Date:  2020-10-12       Impact factor: 4.592

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.